Šiarnik Pavel, Klobučníková Katarína, Mucska Imrich, Černá Katarína, Kollár Branislav, Turčáni Peter
Vnitr Lek. 2018 Fall;64(10):934-938.
Obstructive sleep apnea is a sleep disorder characterized by repetitive partial or complete upper airway obstruction that lead to hemodynamic changes, arousals from sleep and intermittent hypoxia. Obstructive sleep apnea activates multiple pathways that lead to vascular disease. The vascular risk imposed by obstructive sleep apnea may be mediated through the metabolic consequences of sleep-disordered breathing. There is increasing evidence that obstructive sleep apnea is independently associated with dyslipidemia, a well known vascular risk factor. However, the role of obstructive sleep apnea in causality of dyslipidemia remains to be established. Current article focuses on possible mechanisms linking obstructive sleep apnea with the development of dyslipidemia. Possible role of obstructive sleep apnea as a therapeutic target to improve dyslipidemia is also discussed. Key words: dyslipidemia - obstructive sleep apnea.
阻塞性睡眠呼吸暂停是一种睡眠障碍,其特征为反复出现部分或完全性上气道阻塞,导致血流动力学改变、睡眠中觉醒及间歇性缺氧。阻塞性睡眠呼吸暂停激活多种导致血管疾病的途径。阻塞性睡眠呼吸暂停所带来的血管风险可能通过睡眠呼吸紊乱的代谢后果介导。越来越多的证据表明,阻塞性睡眠呼吸暂停与血脂异常独立相关,血脂异常是一种众所周知的血管危险因素。然而,阻塞性睡眠呼吸暂停在血脂异常因果关系中的作用仍有待确定。本文聚焦于将阻塞性睡眠呼吸暂停与血脂异常发生相联系的可能机制。还讨论了阻塞性睡眠呼吸暂停作为改善血脂异常治疗靶点的可能作用。关键词:血脂异常 - 阻塞性睡眠呼吸暂停